BRPI0716163A2 - mÉtodos e kits para detectar fluido cÉrebro-espinhal em uma amostra - Google Patents

mÉtodos e kits para detectar fluido cÉrebro-espinhal em uma amostra

Info

Publication number
BRPI0716163A2
BRPI0716163A2 BRPI0716163-8A2A BRPI0716163A BRPI0716163A2 BR PI0716163 A2 BRPI0716163 A2 BR PI0716163A2 BR PI0716163 A BRPI0716163 A BR PI0716163A BR PI0716163 A2 BRPI0716163 A2 BR PI0716163A2
Authority
BR
Brazil
Prior art keywords
kits
sample
methods
spinal fluid
detecting brain
Prior art date
Application number
BRPI0716163-8A2A
Other languages
English (en)
Inventor
Srinivas N Pentyala
Original Assignee
Stony Brook Anesthesiologists U F P C
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stony Brook Anesthesiologists U F P C filed Critical Stony Brook Anesthesiologists U F P C
Publication of BRPI0716163A2 publication Critical patent/BRPI0716163A2/pt

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896Neurological disorders, e.g. Alzheimer's disease
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/25Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving enzymes not classifiable in groups C12Q1/26 - C12Q1/66
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531Production of immunochemical test materials
    • G01N33/532Production of labelled immunochemicals
    • G01N33/533Production of labelled immunochemicals with fluorescent label
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366Apparatus specially adapted for solid-phase testing
    • G01N33/54386Analytical elements
    • G01N33/54387Immunochromatographic test strips
    • G01N33/54388Immunochromatographic test strips based on lateral flow
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/99Isomerases (5.)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Neurosurgery (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
BRPI0716163-8A2A 2006-09-06 2007-07-27 mÉtodos e kits para detectar fluido cÉrebro-espinhal em uma amostra BRPI0716163A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/516,385 US20070003992A1 (en) 2003-04-09 2006-09-06 Methods and kits for detecting cerebrospinal fluid in a sample
PCT/US2007/016907 WO2008030305A2 (en) 2006-09-06 2007-07-27 Methods and kits for detecting cerebrospinal fluid in a sample

Publications (1)

Publication Number Publication Date
BRPI0716163A2 true BRPI0716163A2 (pt) 2013-09-17

Family

ID=39157733

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0716163-8A2A BRPI0716163A2 (pt) 2006-09-06 2007-07-27 mÉtodos e kits para detectar fluido cÉrebro-espinhal em uma amostra

Country Status (10)

Country Link
US (1) US20070003992A1 (pt)
EP (1) EP2076772A4 (pt)
JP (1) JP2010502984A (pt)
KR (1) KR20090106448A (pt)
CN (1) CN101535807A (pt)
AU (1) AU2007293497A1 (pt)
BR (1) BRPI0716163A2 (pt)
CA (1) CA2662341A1 (pt)
IL (1) IL197311A0 (pt)
WO (1) WO2008030305A2 (pt)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8470608B2 (en) * 2008-05-20 2013-06-25 Rapid Pathogen Screening, Inc Combined visual/fluorescence analyte detection test
US8669052B2 (en) 2008-06-10 2014-03-11 Rapid Pathogen Screening, Inc. Lateral flow nucleic acid detector
US8609433B2 (en) 2009-12-04 2013-12-17 Rapid Pathogen Screening, Inc. Multiplanar lateral flow assay with sample compressor
US9068981B2 (en) 2009-12-04 2015-06-30 Rapid Pathogen Screening, Inc. Lateral flow assays with time delayed components
US20130196310A1 (en) 2008-05-20 2013-08-01 Rapid Pathogen Screening, Inc. Method and Device for Combined Detection of Viral and Bacterial Infections
US8962260B2 (en) 2008-05-20 2015-02-24 Rapid Pathogen Screening, Inc. Method and device for combined detection of viral and bacterial infections
US8815609B2 (en) 2008-05-20 2014-08-26 Rapid Pathogen Screening, Inc. Multiplanar lateral flow assay with diverting zone
US9910036B2 (en) 2008-05-20 2018-03-06 Rapid Pathogen Screening, Inc. Method and device for combined detection of viral and bacterial infections
US20110086359A1 (en) * 2008-06-10 2011-04-14 Rapid Pathogen Screening, Inc. Lateral flow assays
WO2009152209A2 (en) * 2008-06-10 2009-12-17 Rapid Pathogen Screening, Inc. Combined visual/fluorescence analyte detection test
US9182411B2 (en) * 2009-07-14 2015-11-10 Colen Innovations, L.L.C. Methods and apparatus for the detection and differentiation of non-sialated proteins from sialated proteins in a fluid sample
JP2013501919A (ja) 2009-08-07 2013-01-17 アフィニマーク テクノロジーズ,インコーポレイテッド 脳脊髄液の免疫的識別のための装置および方法
CN102798709B (zh) * 2012-08-17 2014-11-19 深圳市锦瑞电子有限公司 一种抗体偶联物及其方法
ES2690782T3 (es) 2012-10-24 2018-11-22 Nyu Winthrop Hospital Biomarcador no invasivo para identificar sujetos en riesgo de parto prematuro
EP3822635A1 (en) 2014-03-07 2021-05-19 The Regents Of The University Of California Devices for integrating analyte extraction, concentration and detection
AU2016318103B2 (en) 2015-09-04 2022-11-17 The Regents Of The University Of California Methods and devices for analyte collection, extraction, concentration, and detection for clinical applications
US10808287B2 (en) 2015-10-23 2020-10-20 Rapid Pathogen Screening, Inc. Methods and devices for accurate diagnosis of infections
AU2017277631B2 (en) 2016-06-09 2024-01-25 The Regents Of The University Of California Biomarker concentration and signal amplification for use in paper-based immunoassays and a single platform for extracting, concentrating, and amplifying DNA
WO2018039139A1 (en) 2016-08-22 2018-03-01 The Regents Of The University Of California Hydrogel platform for aqueous two-phase concentration of a target to enhance its detection
US11209427B2 (en) 2017-03-27 2021-12-28 The Regents Of The University Of California Semi-quantitative lateral-flow immunoassay for the detection of CSF leaks
CN111094988A (zh) 2017-09-13 2020-05-01 普罗根尼蒂公司 先兆子痫生物标志物及相关系统和方法
CN109781997A (zh) * 2019-01-22 2019-05-21 中国人民解放军总医院 用于诊断粘多糖病ⅱ型的生物标志物及其应用
EP4070113A4 (en) 2019-12-04 2023-12-20 Biora Therapeutics, Inc. ASSESSMENT OF PREECLAMPSIA USING FREE AND DISSOCIATE PLACENTAL GROWTH FACTOR TESTS
KR102768080B1 (ko) * 2023-08-30 2025-02-17 인제대학교 산학협력단 우수한 신체적합성을 갖는 뇌척수액 검출용 멀티레이어 시트

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4946778A (en) * 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
ATE195022T1 (de) * 1987-04-27 2000-08-15 Unilever Nv Spezifische bindungstestverfahren
US4981785A (en) * 1988-06-06 1991-01-01 Ventrex Laboratories, Inc. Apparatus and method for performing immunoassays
US5530101A (en) * 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
US6352862B1 (en) * 1989-02-17 2002-03-05 Unilever Patent Holdings B.V. Analytical test device for imuno assays and methods of using same
GB8903627D0 (en) * 1989-02-17 1989-04-05 Unilever Plc Assays
US6277969B1 (en) * 1991-03-18 2001-08-21 New York University Anti-TNF antibodies and peptides of human tumor necrosis factor
AU2402292A (en) * 1991-07-29 1993-03-02 Serex, Inc. Differential binding affinities and dissociation assays based thereon
US5376313A (en) * 1992-03-27 1994-12-27 Abbott Laboratories Injection molding a plastic assay cuvette having low birefringence
FI92882C (fi) * 1992-12-29 1995-01-10 Medix Biochemica Ab Oy Kertakäyttöinen testiliuska ja menetelmä sen valmistamiseksi
US5599677A (en) * 1993-12-29 1997-02-04 Abbott Laboratories Immunoassays for prostate specific antigen
CA2235845C (en) * 1995-10-31 2005-05-17 Maruha Corporation Prostaglandin d synthase-specific monoclonal antibody
CA2239957A1 (en) * 1995-12-22 1997-07-03 Abbott Laboratories Fluorescence polarization immunoassay diagnostic method
US5885529A (en) * 1996-06-28 1999-03-23 Dpc Cirrus, Inc. Automated immunoassay analyzer
MX9602631A (es) * 1996-07-04 1998-01-31 Servicios Condumex Sa Cable de fibras opticas mejorado.
WO1998049559A1 (en) * 1997-04-30 1998-11-05 Maruha Corporation Method for detecting or predicting ischemic diseases
US6394952B1 (en) * 1998-02-03 2002-05-28 Adeza Biomedical Corporation Point of care diagnostic systems
US6458549B2 (en) * 1998-06-11 2002-10-01 Winthrop-University Hospital Methods of diagnosing renal salt wasting syndrome and Alzheimer's disease and methods of treating the same
JP2000249709A (ja) * 1999-02-26 2000-09-14 Maruha Corp 冠血管インターベンション施行後の再狭窄の予測方法
US6812329B2 (en) * 2001-02-27 2004-11-02 Her Majesty The Queen In Right Of Canada, As Represented By The Minister Of National Defence Construction and characterization of monoclonal antibodies against western equine encephalitis virus
US7524635B2 (en) * 2003-04-17 2009-04-28 Biosite Incorporated Methods and compositions for measuring natriuretic peptides and uses thereof
WO2003105899A1 (en) * 2002-06-13 2003-12-24 Neuropro Technologies, Inc. Apparatus and methods for detecting cerebrospinal fluid
US20040203079A1 (en) * 2003-04-09 2004-10-14 Research Foundation Of The State University Of New York Methods and kits for detecting cerebrospinal fluid in a sample

Also Published As

Publication number Publication date
CA2662341A1 (en) 2008-03-13
WO2008030305A3 (en) 2008-05-02
IL197311A0 (en) 2009-12-24
JP2010502984A (ja) 2010-01-28
KR20090106448A (ko) 2009-10-09
CN101535807A (zh) 2009-09-16
AU2007293497A1 (en) 2008-03-13
US20070003992A1 (en) 2007-01-04
EP2076772A4 (en) 2010-10-20
EP2076772A2 (en) 2009-07-08
WO2008030305A2 (en) 2008-03-13

Similar Documents

Publication Publication Date Title
BRPI0716163A2 (pt) mÉtodos e kits para detectar fluido cÉrebro-espinhal em uma amostra
BRPI0701921A (pt) aparelho para obter uma pluralidade de amostras de fluido em um poço subterráneo e método para obter uma pluralidade de amostras de fluido em um poço subterráneo
BRPI0815231A2 (pt) Aparelho para o fundo do poço visando detectar gás de fluido de retorno e método para detecção de gás de fluido de retorno no fundo do poço
IL223604B (en) System for detection of an analyte in a body fluid
EP2235203A4 (en) MICROBIOLOGICAL SYSTEMS AND METHODS FOR LIQUID SAMPLE ANALYSIS
GB2445745B (en) System and method for analysis of well fluid samples
BRPI0906858A2 (pt) Métodos para detecção de assinaturas de doença ou condições em fluidos corporais
BRPI0910948A2 (pt) aparelho e método para analisar um fluido
GB2461379B (en) Methods and apparatus for downhole fluids analysis
BRPI0917910A2 (pt) método para detectar amostra de aspereza e aparelho para o método
BRPI0819608A2 (pt) métodos para monitorar escoamento de fluido e para produzir hidrocarbonetos
BRPI0817874A2 (pt) Método e sistema para registrar e mensuar vazamentos e fluxos
EP2057435A4 (en) SYSTEMS AND METHOD FOR COOLING IN DEVICES FOR BIOLOGICAL ANALYSIS
GB2442105B (en) Biological fluid analysis system
BRPI0920005A2 (pt) instrumento e sistema para produzir uma amostra de um líquido de corpo e para análise do mesmo
BRPI0906845A2 (pt) Método e aparelho para avaliação de uma propriedade de fluido de fundo de poço.
BRPI0821148A2 (pt) Dispositivo e método para análise microbiológica de amostras biológicas
BRPI0820914A2 (pt) Kit para teste de células e método
BRPI0923606A2 (pt) dispositivo e método para aplicação de fluido
BRPI1009528A2 (pt) ferramenta de fundo de poço para a análise de líquidos no fundo de poço, método e método para uso em uma ferramenta de poço
GB0813052D0 (en) System and method for obtaining well fluid samples
BRPI0817068A2 (pt) dispositivo e método para medir consumo/perfusão de oxigênio regional
BRPI0915736A2 (pt) dispositivo para analisar uma amostra química ou biológica
BRPI0820721A2 (pt) Reagentes e métodos para detectar analitos
BRPI0822018A2 (pt) Processo de análise de uma pluralidade de hidrocarbonetos contidos em um fluido de perfuração e dispositivo associado

Legal Events

Date Code Title Description
B08L Patent application lapsed because of non payment of annual fee [chapter 8.12 patent gazette]

Free format text: REFERENTE AO NAO RECOLHIMENTO DAS 5A, 6A E 7A ANUIDADES.

B08I Publication cancelled [chapter 8.9 patent gazette]

Free format text: ANULADA A PUBLICACAO CODIGO 8.12 NA RPI NO 2277 DE 26/08/2014 POR TER SIDO INDEVIDA.

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 5A, 6A, 7A, 8A, 9A, 10A, 11A, 12A E 13A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2602 DE 17-11-2020 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.